# Imvaq Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imvaq-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.imvaq.com
- Total disclosed funding: $15M
- Latest round: Series B (Sep 28, 2020)
- Investors on record: 1

## About

Imvaq Therapeutics Corp. is a biotechnology firm focused on developing innovative therapeutics aimed at enhancing patient outcomes in oncology through advanced treatment modalities.Founded in 2016 and headquartered in New York, US, Imvaq Therapeutics Corp. specializes in transformative therapies for cancer treatment. The company has raised a total of USD 15.00 mn, with a Series B funding round led by Hanne Capital in September 2020. The founder, John Choi, is recognized for his expertise in therapeutic developments.Imvaq Therapeutics Corp. provides a range of innovative therapeutic solutions specifically designed to address oncology market needs. Their core offerings focus on advanced treatment modalities aimed at enhancing patient outcomes, utilized by healthcare institutions including hospitals and clinical research organizations. The company primarily markets its products in North America and Europe, with plans for expansion into emerging markets.Imvaq Therapeutics Corp. generates revenue through direct sales of its therapeutics and by engaging clients through tailored service agreements which ensure ongoing support and updates. This model fosters long-term client relationships and includes comprehensive service packages aimed at maximizing value for healthcare providers.Imvaq Therapeutics Corp. plans to utilize the recent USD 15.00 mn raised in their Series B funding to advance the development and launch of new oncology products slated for release in the coming years. The company aims to expand its market reach into Asia and Latin America by 2023, reinforcing its commitment to enhancing cancer treatment accessibility globally.

## Funding rounds

- Series B, Sep 28, 2020, $15M — Hanne Capital

## Investors

- Hanne Capital (https://capitalatlas.ai/funds/hanne-capital) — Series B